Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
ConditionDelirium
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorBoston Medical Center
About this trial
In this pilot study a new kind of music therapy will be created and tested to help prevent confusion, called delirium, that can happen in the hospital. This can affect people with brain diseases like Alzheimer's disease and Parkinson's disease.
Each of the anticipated 30 participants will have up to five music therapy sessions. The sessions will be made just for them and may include live music, playing instruments, or listening to recorded music. Surveys will be used to learn how easy the therapy is to do in the hospital and what people think about how helpful the sessions may be for future patients.
Eligibility criteria
Qualifiers
Admitted as inpatient to Boston Medical Center.
Diagnosis of Parkinson's Disease, Dementia with Lewy Bodies (ICD-10 G20 and G31.83 respectively), Alzheimer's Disease-related dementias (ICD-10 6D80), vascular dementia (F01), or other cognitive impairment (R41) on active problem list or past medical history
"Cognitive impairment" on active problem list or past medical history
Documentation elsewhere in the electronic medical record (e.g. notes) of any of these conditions
Disqualifiers
Admitted to observation status (as these patients would not be expected to remain inpatient long enough to undergo the MT intervention)
Patients who will be discharged within 24 hours of eligibility based on discussion with primary admitting team
Self-reported history of musicogenic seizures
Hearing loss: unable to hear a recorded sound <70 decibels (dB)
Trial design
Treatments tested in this trial
- Music therapy
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov